🦠 microbiology

Animal-free peptones do not alter bacteriophages propagated for therapeutic use

This study demonstrates that animal-free peptones can be used as a safe and effective alternative to traditional animal-derived media for propagating therapeutic bacteriophages, as they produce comparable yields, bactericidal activities, and genomic stability without significant alterations.

Original authors: Laucirica, D. R., Carr, P. G., Hedges, M. G., Vaitekenas, A., Velickovic, Z., Stick, S. M., Montgomery, S. T., Kicic, A.

Published 2026-02-26

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Laucirica, D. R., Carr, P. G., Hedges, M. G., Vaitekenas, A., Velickovic, Z., Stick, S. M., Montgomery, S. T., Kicic, A.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine you are a master chef trying to bake the perfect cake. For years, the only recipe you've used calls for a very specific, expensive ingredient: eggs. But now, you want to bake these cakes for a hospital kitchen that has strict rules: "No animal products allowed!" You worry that if you swap the eggs for a plant-based substitute, the cake might not rise, it might taste weird, or worse, it might make people sick.

This scientific paper is essentially a taste test to see if that plant-based substitute works just as well as the eggs.

Here is the story of the paper, broken down into simple concepts:

The Main Characters

The Bacteriophages (Phages): Think of these as tiny, microscopic "pac-man" viruses. They are natural enemies of bacteria. Doctors use them as a super-weapon to kill "superbugs" (bacteria that antibiotics can't stop).
The Bacteria: The "bad guys" (like Pseudomonas and Staphylococcus) that the phages need to eat to multiply.
The Growth Medium (The Soup): To make enough phages to treat a patient, scientists have to grow them in a giant vat of liquid "soup." Traditionally, this soup contains peptones (nutrients) made from animal parts (like cow milk or pig enzymes).
The Problem: Making medicine with animal parts is risky. It's like using a shared spoon to feed a baby; there's a tiny chance the spoon could carry a hidden virus or bacteria from the animal that could hurt the human patient. Regulatory agencies (the "food safety inspectors" of medicine) are saying, "We need to stop using animal parts in medicine if we can."

The Experiment: The Great Swap

The scientists asked a simple question: "If we swap the animal-based soup for a plant-based (animal-free) soup, will our phage 'pac-mans' still work?"

They took 9 different types of phages and grew them in two different kitchens:

The Old Kitchen: Using traditional animal-based soup (Tryptone).
The New Kitchen: Using a new, animal-free plant-based soup (Soytone).

The Results: A Perfect Match

After growing the phages in both kitchens, they put them to the test. Here is what they found, using some fun analogies:

1. Did they grow big enough? (The Yield)

The Test: They counted how many phages were in the soup.
The Result: Yes! The phages in the plant-based soup grew just as big and numerous as the ones in the animal soup. It's like the plant-based eggs made the cake rise exactly the same height.

2. Did they still kill the bad bacteria? (The Activity)

The Test: They dropped the phages onto a plate of bad bacteria to see if they could wipe them out.
The Result: Yes! The phages from the plant soup were just as hungry and effective at killing bacteria as the ones from the animal soup. They didn't get lazy or lose their appetite.

3. Did they change their DNA? (The Safety)

The Test: This is the most important part. Sometimes, when you change a creature's environment, it might mutate or change its personality. The scientists read the entire "instruction manual" (the genome) of the phages and the bacteria to see if the plant soup changed them.
The Result: No changes found. The phages grown in plant soup were genetically identical to the ones grown in animal soup. They didn't pick up any bad genes, and they didn't turn into "lazy" viruses that stop killing bacteria. They remained exactly the same "pac-man" they were supposed to be.

The Conclusion

The scientists concluded that we can safely switch to animal-free soup for making these life-saving medicines.

Why does this matter?

Safety: It removes the risk of animal viruses accidentally getting into the medicine.
Religion & Ethics: It makes the medicine acceptable for people who avoid animal products for religious or ethical reasons.
Future: It opens the door for making these medicines on a massive scale (like a factory) without worrying about animal supply chains.

The Bottom Line

Think of this study as a successful "product swap." The scientists proved that you don't need the "animal ingredient" to make a high-quality, safe, and effective medicine. The plant-based alternative works perfectly, ensuring that the "pac-man" viruses remain ready to fight superbugs without any hidden risks.

1. Problem Statement

The clinical translation of bacteriophage (phage) therapy is hindered by a lack of standardized manufacturing guidelines and regulatory concerns regarding the use of animal-derived materials.

Regulatory Context: Current Good Manufacturing Practice (GMP) guidelines from major regulatory bodies (EMA, FDA, MHRA, WHO) discourage animal-derived ingredients in medicinal products due to the risk of transmitting adventitious agents (e.g., prions, viruses).
Current Practice: Traditional phage propagation relies on media containing animal-derived peptones (e.g., tryptone from bovine casein).
The Gap: While animal-free (AF) alternatives exist, there is insufficient data on whether substituting animal-derived peptones with animal-free sources (e.g., soy-based soytone) affects:
1. Phage yield and titers.
2. Bactericidal activity (efficacy against bacteria).
3. Genomic integrity of the phages and their bacterial hosts (risk of selecting for undesirable variants or lysogeny).

2. Methodology

The study employed a comparative approach using nine obligately lytic phages (8 targeting Pseudomonas aeruginosa and 1 targeting Staphylococcus aureus) propagated in two distinct media formulations:

Control (LB): Traditional Luria-Bertani media containing animal-derived tryptone.
Experimental (AF): Animal-free media containing animal-free soytone.

Experimental Workflow:

Propagation: Phages were propagated in both solid (agar overlay) and liquid (broth) media using both AF and LB formulations.
Phenotypic Assessment:
- Titration: Plaque forming units (PFU/mL) were measured to assess yield.
- Kinetic Assays: Bacterial growth suppression was monitored over 16 hours via OD600nm turbidity measurements. Suppression indices and Area Under the Curve (AUC) were calculated.
- Screening: Spot tests and Efficiency of Plating (EOP) assays were conducted against novel bacterial targets to evaluate virulence and host range.
Genomic Assessment:
- Whole Genome Sequencing (WGS): Long-read sequencing (Oxford Nanopore PromethION) was performed on both the phages and their bacterial hosts grown in AF vs. LB media.
- Bioinformatics: Assemblies were annotated to compare genome size, gene content, defense systems (in bacteria), anti-defense mechanisms, and receptor binding proteins (RBPs). Variant calling was used to identify Single Nucleotide Polymorphisms (SNPs) and indels.

3. Key Contributions

Systematic Dual Assessment: This is one of the first studies to systematically combine phenotypic (yield, activity) and genomic (WGS) assessments of phages and hosts across animal-free and traditional media.
Validation of Animal-Free Media: It provides empirical evidence supporting the use of animal-free peptones for GMP-compliant phage manufacturing.
Methodological Comparison: It evaluates both solid and liquid propagation methods, confirming that broth-based propagation (scalable for industry) performs equivalently to solid propagation in AF media.
Genomic Stability Data: It addresses regulatory concerns by demonstrating that media composition does not induce genomic drift or the acquisition of lysogenic markers in phages.

4. Key Results

Phage Yield:
- No significant difference in phage titers was observed between AF and LB media. Both formulations supported high-titer growth ( $\ge 10^8$ PFU/mL).
- Minor exceptions showed slight titer increases in AF media for specific phages, but overall, peptone source was not a determinant of yield.
Bactericidal Activity:
- Kinetic Assays: Phage suppression indices were statistically identical between AF and LB groups. While bacterial growth in positive controls (no phage) was slightly higher in AF broth, the relative suppression caused by the phages was consistent.
- Screening: Spot tests and EOP scores against novel bacterial targets showed no difference in virulence classification (highly, moderately, or avirulent) regardless of the propagation medium.
Genomic Integrity:
- Phage Genomes: Average Nucleotide Identity (ANI) between AF and LB phages was >99%. Only 5 variants were detected, primarily in hypothetical proteins and one structural protein, with no functional impact on receptor binding or anti-defense mechanisms.
- Host Genomes: No significant differences in bacterial genome size, gene annotations, or defense system repertoires were found between hosts grown in AF vs. LB media.
- Safety Markers: Phages remained obligately lytic in both media (no integrase genes or lysogeny markers detected). No transduction of deleterious bacterial genes (e.g., virulence or AMR genes) was observed.

5. Significance and Conclusion

Regulatory Compliance: The findings support the adoption of animal-free media for the manufacture of medicinal phages, aligning with emerging regulatory guidance to minimize animal-derived risks.
Scalability: The study confirms that animal-free media is suitable for both research-scale and scalable liquid propagation, a critical step for industrial manufacturing.
Safety Assurance: The lack of genomic alterations suggests that switching to animal-free media does not compromise the safety profile or genetic stability of the therapeutic product.
Future Outlook: While the study validates AF media for common pathogens like P. aeruginosa and S. aureus, the authors note that fastidious bacteria requiring specific animal-derived factors may still necessitate animal-derived media, requiring case-by-case risk analysis.

Conclusion: Animal-free peptones are a viable, safe, and effective alternative to traditional animal-derived peptones for the propagation of therapeutic bacteriophages, maintaining high yield, bactericidal efficacy, and genomic stability.